Recent progress in drug delivery
By Chong Li, Jiancheng Wang, Yiguang Wang, Huile Gao, G. Wei, Yongzhuo Huang, Haijun Yu, Yong Gan, Yongjun Wang, L. Mei and 4 more. Acta Pharmaceutica Sinica B, 2019
644 citations recorded by the source corpus.
Drug delivery systems (DDS) are defined as methods by which drugs are delivered to desired tissues, organs, cells and subcellular organs for drug release and absorption through a variety of drug carriers. Its usual purpose to improve the pharmacological activities of therapeutic drugs and to overcome problems such as limited solubility, drug aggregation, low bioavailability, poor biodistribution, lack of selectivity, or to reduce the side effects of therapeutic drugs. During 2015–2018, significant progress in the research on drug delivery systems has been achieved along with advances in related fields, such as pharmaceutical sciences, material sciences and biomedical sciences. This review provides a concise overview of current progress in this research area through its focus on the delivery strategies, construction techniques and specific examples. It is a valuable reference for pharmaceutical scientists who want to learn more about the design of drug delivery systems.
Subfields: Biomaterials, Biomedical Engineering, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/10404715bf456fbd7e5afc74992c7836ba2aca68
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Lulu Cai
- Rehmat Islam
- Yangbao Miao
- Rongsheng Tong
- Hongmei Liu
- Yang Lei
- Leming Sun
- Sumin Tan
Citations in the corpus
- Smart nanoparticles for cancer therapy (2023, background): “4) photocrosslinking group, such as coumarin, cinnamoyl, anthracene, etc. 175,176 The photocleavage type drug delivery system contains a photo-fragmentation group, which undergoes a chemical bond cleavage reaction under UV or NIR irradiation, which causes the structure of the drug delivery system…”